Related Experiment Videos

Long Noncoding RNA XIST Promotes Osteosarcoma Progression by Targeting Ras-Related Protein RAP2B via miR-320b

Gong-Yi Lv1, Jun Miao1, Xiao-Lin Zhang1

  • 1Department of Spinal Surgery, Tianjin Hospital, Tianjin, P.R. China.

Oncology Research
|April 15, 2017
PubMed

Insights

Long noncoding RNA XIST promotes osteosarcoma progression by inhibiting miR-320b, leading to increased proliferation and invasion. Targeting XIST may offer new therapeutic strategies for osteosarcoma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Abnormal long noncoding RNA (lncRNA) expression is linked to cancer progression.
  • X-inactive specific transcript (XIST) is upregulated in various cancers, but its role in osteosarcoma (OS) remains unclear.

Purpose of the Study:

  • To investigate the mechanism of lncRNA XIST in osteosarcoma (OS) cell proliferation and invasion.
  • To explore the relationship between XIST, miR-320b, and RAP2B in OS.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and LncRNA Profiler to assess XIST expression.
  • MTT and Transwell invasion assays to evaluate cell proliferation and invasion.
  • Luciferase reporter assay to confirm the interaction between XIST and miR-320b.

Main Results:

  • XIST expression was significantly elevated in OS tissues and cell lines.
  • XIST knockdown inhibited OS cell proliferation and invasion.
  • XIST directly targets and represses miR-320b, affecting the miR-320b/RAP2B axis.

Conclusions:

  • XIST promotes osteosarcoma cell proliferation and invasion via the miR-320b/RAP2B pathway.
  • lncRNA XIST is a potential prognostic biomarker and therapeutic target for osteosarcoma.

Related Concept Videos